Antineoplastic And Immunomodulating Agents – Drug Supplies – Mepolizumab 2026. The Subject Of Performance Is Continuous Deliveries According To Annex No. 1 Of The Purchase Agreement – Price Offer, Within The Scope And In Accordance With The Tender Conditions, Namely The Supply Of Medicinal Products Mepolizumab – R03dx09.
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
